Country	ProductionDate	ISOCountryCode	Vaccine	Year	WUENIC	WUENICPreviousRevision	GradeOfConfidence	AdministrativeCoverage	GovernmentEstimate	ReportedCoverage	ChildrenVaccinated	ChildrenInTarget	BirthsUNPD	SurvivingInfantsUNPD	ReportedTimeSeries	ReportedTimeSeriesSource	SurveyInformation	Rule	Comment	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	1997	98	98	2		98	98			646054	646054	98	gov		R: AP	Legacy estimate.   GoC=R+ S+	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	1998	96	96	2		96	96			640417	640417	96	gov		R:	Estimate informed by reported data.    GoC=R+ S+	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	1999	97	97	2	98	97	97			636064	636064	97	gov	96	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 96 percent based on 1 survey(s).    GoC=R+ S+	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2000	93	93	3	93	93	93	547622	587552	633322	633322	93	gov		R:	Estimate informed by reported data.    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2001	87	87	3	87	87	87	517947	586577	620232	620232	87	gov		R:	Estimate informed by reported data.    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2002	92	92	2	92	92	92			616261	616261	92	gov		R:	Estimate informed by reported data.    GoC=R+ S+	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2003	94	94	3	94	94	94	549705	584275	615508	615508	94	gov	95	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 95 percent based on 2 survey(s).    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2004	95	95	3	91	91	91	555164	605682	623674	623674	95	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2005	95	95	3	93	93	93	559871	602739	631197	631197	95	interpolated	95	R: AP	Estimate informed by interpolation between reported data supported by survey. Survey evidence of 95 percent based on 1 survey(s).  Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2006	96	96	3	100	100	100	551971	550011	634801	634801	96	interpolated	96	R: AP	Estimate informed by interpolation between reported data supported by survey. Survey evidence of 96 percent based on 1 survey(s).  Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2007	96	96	1	105	105	105	526563	500748	632563	632563	96	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.Reported data excluded because 105 percent greater than 100 percent.   Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2008	97	97	1	108	108	108	540897	500672	626301	626301	97	interpolated		R:	Estimate informed by interpolation between reported data.  Peru Continuous Demographic and Health Survey 2009 results ignored by working group.  Survey results ignored. Adjustment factor for recall bias inconsistent with other surveys of similar quality and methodology.Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.Reported data excluded because 108 percent greater than 100 percent.   Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2009	97	97	3	97	97	97	578515	596227	623635	623635	97	gov	90	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 90 percent based on 1 survey(s).    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2010	95	95	3	95	95	95	565346	593470	617632	617632	95	gov	95	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 95 percent based on 1 survey(s).    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2011	91	91	3	91	91	91	538153	589273	613180	613180	91	gov	94	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 94 percent based on 1 survey(s).    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2012	95	95	3	95	95	95	553302	582056	602813	602813	95	gov	93	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 93 percent based on 1 survey(s).    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2013	95	95	3	95	95	95	545631	574322	592938	592938	95	gov		R:	Estimate informed by reported data.  The 2014 ENDESA survey reporting coverage for children aged less than 12 months (87 percent of whom had documented evidence of vaccination history), born during 2013, suggests coverage (card+recall) of 91 percent for BCG.  GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2014	94	94	3	94	94	94	534931	567358	584699	584699	94	gov		R:	Estimate informed by reported data.   GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2015	91	91	2	91	91	91	514243	562442	577568	577568	91	gov		R:	Estimate informed by reported data.   GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2016	90	90	2	90	90	90	487445	539608	575208	575208	90	gov		R:	Estimate informed by reported data.   GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2017	91	84	1	81	81	81	458286	568870	576461	576461	91	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years. Estimate of 91 percent changed from previous revision value of 84 percent.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2018	93	81	2	94	94	94	501254	535761	579697	579697	93	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years. Estimate of 93 percent changed from previous revision value of 81 percent.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2019	94	94	1	94	94	94	476149	506008	591025	591025	94	gov		R:	Estimate informed by reported data.  Increase in reported coverage is partially due a six percent decrease in the reported target population from 2018 to 2019..  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2020	87	87	1	87	87	87	439542	506008	593207	593207	87	gov		R:	Estimate informed by reported data.  Decline in reported coverage is unexplained by country but aligns with COVID-19 pandemic service disruptions.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2021	87	87	1	87	87	87	439297	506008	593523	593523	87	gov		R:	Estimate informed by reported data.   Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	bcg	2022	89		1	89	89	89	441112	494595	592156	592156	89	gov		R:	Estimate informed by reported data.  WHO and UNICEF are aware of a 2021 Peru Encuesta Demográfica y de Salud Familiar-ENDES 2021 that reports BCG coverage of 92 percent for children under 36 months of age.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	1997	96	96	2						646054	646054	91	extrapolated		W: AP	Estimate of 96 percent assigned by working group. Legacy estimate.   GoC=S+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	1998	94	94	2						640417	640417	91	extrapolated		C:	Reported data calibrated to 1997 and 1999 levels.    GoC=S+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	1999	99	99	2						636064	636064	91	extrapolated	96	RMF:	DTP1 coverage estimated based on DTP3 coverage of 99.    GoC=S+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2000	99	99	1	91	91	91	536461	587552	633322	633322	91	gov		RMF:	DTP1 coverage estimated based on DTP3 coverage of 98.    Estimate challenged by: D-R-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2001	91	91	2						620232	620232	91	interpolated		R:	Estimate informed by interpolation between reported data.    GoC=S+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2002	98	98	1		91	91			616261	616261	91	gov		RMF:	DTP1 coverage estimated based on DTP3 coverage of 95.    Estimate challenged by: R-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2003	98	98	1	92		92	535004	584275	615508	615508	92	admin	98	RMF:	DTP1 coverage estimated based on DTP3 coverage of 94.    Estimate challenged by: D-R-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2004	93	93	1	84	84	84	722066	605682	623674	623674	93	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2005	94	94	1	87	87	87	525742	602739	631197	631197	94	interpolated	96	R: AP	Estimate informed by interpolation between reported data supported by survey. Survey evidence of 96 percent based on 1 survey(s).  Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2006	96	96	1	98	98	98	540020	550011	634801	634801	96	interpolated	96	R: AP	Estimate informed by interpolation between reported data supported by survey. Survey evidence of 96 percent based on 1 survey(s).  Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2007	93	93	1	113	113	113	519703	500748	632563	632563	97	interpolated		C:	Reported data calibrated to 2006 and 2009 levels.  Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.Reported data excluded because 113 percent greater than 100 percent.   Estimate challenged by: D-R-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2008	97	97	1	110	110	110	552359	500672	626301	626301	98	interpolated		RMF:	DTP1 coverage estimated based on DTP3 coverage of 93.  Peru Continuous Demographic and Health Survey 2009 results ignored by working group.  Survey results ignored. Adjustment factor for recall bias inconsistent with other surveys of similar quality and methodology.Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.Reported data excluded because 110 percent greater than 100 percent.   Estimate challenged by: R-S-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2009	97	97	1	99	99	99	591348	596227	623635	623635	99	gov	86	RMF:	DTP1 coverage estimated based on DTP3 coverage of 93.    Estimate challenged by: R-S-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2010	97	97	1	97	97	97	572737	593470	617632	617632	97	gov	91	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 91 percent based on 1 survey(s).    Estimate challenged by: S-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2011	94	94	3	94	94	94	556682	589273	613180	613180	94	gov	93	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 93 percent based on 1 survey(s).    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2012	99	99	3	100	100	100	580833	582056	602813	602813	100	gov	93	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 93 percent based on 1 survey(s).    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2013	97	97	3	97	97	97	555220	574322	592938	592938	97	gov		R:	Estimate informed by reported data.  The 2014 ENDESA survey reporting coverage for children aged less than 12 months (87 percent of whom had documented evidence of vaccination history), born during 2013, suggests coverage (card+recall) of 89 percent for first dose of DTP-HepB-Hib.  GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2014	98	98	3	98	98	98	556796	567358	584699	584699	98	gov		R:	Estimate informed by reported data.   GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2015	97	97	2	97	97	97	547309	562442	577568	577568	97	gov		R:	Estimate informed by reported data.   GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2016	94	94	2	94	94	94	506373	539608	575208	575208	94	gov		R:	Estimate informed by reported data.   GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2017	95	90	1	85	85	85	484484	568870	576461	576461	95	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years. Estimate of 95 percent changed from previous revision value of 90 percent.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2018	96	90	2	104	104	104	559475	535761	579697	579697	96	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years.Reported data excluded because 104 percent greater than 100 percent.  Estimate of 96 percent changed from previous revision value of 90 percent.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2019	97	97	1	97	97	97	489258	506008	591025	591025	97	gov		R:	Estimate informed by reported data.  Increase in reported coverage is partially due a six percent decrease in the reported target population from 2018 to 2019.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2020	93	93	1	93	93	93	470429	506008	593207	593207	93	gov		R:	Estimate informed by reported data.  Decline in reported coverage is unexplained by country but aligns with COVID-19 pandemic service disruptions.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2021	90	90	1	90	90	90	455944	506008	593523	593523	90	gov		R:	Estimate informed by reported data.   Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp1	2022	93		1	93	93	93	458333	494595	592156	592156	93	gov		R:	Estimate informed by reported data.  WHO and UNICEF are aware of a 2021 Peru Encuesta Demográfica y de Salud Familiar-ENDES 2021 that reports DTP-HepB-Hib1 coverage of 91 percent for children under 36 months of age.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	1997	90	90	1		98	98			646054	646054	98	gov		W: AP	Estimate of 90 percent assigned by working group. Legacy estimate.   Estimate challenged by: R-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	1998	94	94	1		98	98			640417	640417	98	gov		C:	Reported data calibrated to 1997 and 1999 levels.    Estimate challenged by: R-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	1999	99	99	2	99	99	99			636064	636064	99	gov	93	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 93 percent based on 1 survey(s).  NA card or history results of 85 percent modifed for recall bias to 93 percent based on 1st dose card or history coverage of 96 percent, 1st dose card only coverage of 58 percent and 3rd dose card only coverage of 56 percent.   GoC=R+ S+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2000	98	98	3	98	98	98	574213	587552	633322	633322	98	gov		R:	Estimate informed by reported data.    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2001	90	90	3	90	90	90	535545	586577	620232	620232	90	gov		R:	Estimate informed by reported data.    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2002	95	95	2	95	95	95			616261	616261	95	gov		R:	Estimate informed by reported data.    GoC=R+ S+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2003	94	94	1	94	94	94	550406	584275	615508	615508	94	gov	95	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 95 percent based on 2 survey(s).  Peru Demographic and Health Survey 2004 card or history results of 87 percent modifed for recall bias to 94 percent based on 1st dose card or history coverage of 97 percent, 1st dose card only coverage of 66 percent and 3rd dose card only coverage of 64 percent. Peru Demographic and Health Survey, 2004-2008 - Final Report Continuous (2004-2005) card or history results of 85 percent modifed for recall bias to 95 percent based on 1st dose card or history coverage of 98 percent, 1st dose card only coverage of 68 percent and 3rd dose card only coverage of 66 percent.   Estimate challenged by: S-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2004	86	86	1	91	91	91		605682	623674	623674	94	interpolated		C:	Reported data calibrated to 2003 and 2005 levels.  Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: R-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2005	77	77	1	89	89	89	538758	602739	631197	631197	94	interpolated	77	S: AP	Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 77 percent based on 1 survey(s).   Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: R-S-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2006	94	94	1	94	94	94	519429	550011	634801	634801	94	interpolated	90	R: AP	Estimate informed by interpolation between reported data supported by survey. Survey evidence of 90 percent based on 1 survey(s).  Peru Continuous Demographic and Family Health Survey 2007-2008 card or history results of 76 percent modifed for recall bias to 90 percent based on 1st dose card or history coverage of 96 percent, 1st dose card only coverage of 62 percent and 3rd dose card only coverage of 58 percent. Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: D-S-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2007	93	93	1	97	101	101	436988	500748	632563	632563	93	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.Reported data excluded because 101 percent greater than 100 percent.   Estimate challenged by: D-S-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2008	93	93	1	99	99	99	494478	500672	626301	626301	93	interpolated		R:	Estimate informed by interpolation between reported data.  Peru Continuous Demographic and Health Survey 2009 results ignored by working group.  Survey results ignored. Adjustment factor for recall bias inconsistent with other surveys of similar quality and methodology.Peru Continuous Demographic and Health Survey 2009 card or history results of 73 percent modifed for recall bias to 89 percent based on 1st dose card or history coverage of 96 percent, 1st dose card only coverage of 65 percent and 3rd dose card only coverage of 60 percent. Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: D-S-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2009	93	93	1	93	93	93	551504	596227	623635	623635	93	gov	79	R: AP	 Estimate based on reported data. Peru Continuous Demographic and Family Health Survey 2010 card or history results of 74 percent modifed for recall bias to 79 percent based on 1st dose card or history coverage of 86 percent, 1st dose card only coverage of 75 percent and 3rd dose card only coverage of 69 percent.   Estimate challenged by: S-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2010	93	93	1	93	93	93	548965	593470	617632	617632	93	gov	86	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 86 percent based on 1 survey(s).  Peru Continuous Demographic and Family Health Survey 2011 card or history results of 81 percent modifed for recall bias to 86 percent based on 1st dose card or history coverage of 91 percent, 1st dose card only coverage of 79 percent and 3rd dose card only coverage of 75 percent.   Estimate challenged by: S-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2011	91	91	1	91	91	91	539643	589273	613180	613180	91	gov	88	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 88 percent based on 1 survey(s).  Peru Continuous Demographic and Family Health Survey 2012 card or history results of 83 percent modifed for recall bias to 88 percent based on 1st dose card or history coverage of 93 percent, 1st dose card only coverage of 80 percent and 3rd dose card only coverage of 76 percent.   Estimate challenged by: S-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2012	95	95	3	95	95	95	554400	582056	602813	602813	95	gov	88	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 88 percent based on 1 survey(s).  Peru Continuous Demographic and Family Health Survey 2013 card or history results of 80 percent modifed for recall bias to 88 percent based on 1st dose card or history coverage of 93 percent, 1st dose card only coverage of 78 percent and 3rd dose card only coverage of 74 percent.   GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2013	88	88	3	88	88	88	506490	574322	592938	592938	88	gov		R:	Estimate informed by reported data. The 2014 ENDESA survey reporting coverage for children aged less than 12 months (87 percent of whom had documented evidence of vaccination history), born during 2013, suggests coverage (card+recall) of 70 percent modified for recall bias to 72 percent based on 1st dose card or history coverage of 89 percent, 1st dose card only coverage of 82 percent and 3d dose card only coverage of 66 percent.  GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2014	88	88	3	88	88	88	500868	567358	584699	584699	88	gov		R:	Estimate informed by reported data.  Increase in dropout due to multiple factors per EPI review 2014.  GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2015	90	90	2	90	90	90	507770	562442	577568	577568	90	gov		R:	Estimate informed by reported data.   GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2016	89	89	2	89	89	89	478326	539608	575208	575208	89	gov		R:	Estimate informed by reported data.   GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2017	89	83	1	79	79	79	451561	568870	576461	576461	89	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years. Estimate of 89 percent changed from previous revision value of 83 percent.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2018	88	84	2	97	97	97	517500	535761	579697	579697	88	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years. Estimate of 88 percent changed from previous revision value of 84 percent.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2019	88	88	1	88	88	88	445867	506008	591025	591025	88	gov		R:	Estimate informed by reported data.  Increase in reported coverage is partially due a six percent decrease in the reported target population from 2018 to 2019.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2020	72	72	1	72	72	72	365435	506008	593207	593207	72	gov		R:	Estimate informed by reported data.  Decline in reported coverage is unexplained by country but aligns with COVID-19 pandemic service disruptions..  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2021	82	82	1	82	82	82	412409	506008	593523	593523	82	gov		R:	Estimate informed by reported data.   Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	dtp3	2022	82		1	82	82	82	406912	494595	592156	592156	82	gov		R:	Estimate informed by reported data.  WHO and UNICEF are aware of a 2021 Peru Encuesta Demográfica y de Salud Familiar-ENDES 2021 that reports DTP-HepB-Hib3 coverage of 81 percent for children under 36 months of age.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	hepb3	2003	65	65	1	60	60	60	353221	584275	615508	615508	60	gov		C:	Reported data calibrated to 2005 levels.   HepB vaccine partially introduced in 1998, nationally in 2005, and reporting started in 2003.  Estimate challenged by: R-	
Peru	Wed Sep 06 19:01:34 2023	per	hepb3	2004	92	92	1	50	87	87	304699	605682	623674	623674	87	gov		C:	Reported data calibrated to 2005 levels.    Estimate challenged by: D-R-	
Peru	Wed Sep 06 19:01:34 2023	per	hepb3	2005	94	94	1	89	89	89	464067	1205478	631197	631197	89	gov		W: AP	Estimate of 94 percent assigned by working group.  Estimate is based on DTP3 coverage levels.   Estimate challenged by: D-R-	
Peru	Wed Sep 06 19:01:34 2023	per	hepb3	2006	94	94	1	94	94	94	519429	550011	634801	634801	90	interpolated		W: AP	Estimate of 94 percent assigned by working group.  Estimate is based on DTP3 coverage levels. Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: D-R-	
Peru	Wed Sep 06 19:01:34 2023	per	hepb3	2007	93	93	1	96	93	93	436988	500748	632563	632563	91	interpolated		W: AP	Estimate of 93 percent assigned by working group.  Estimate is based on DTP3 coverage levels. Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: D-R-	
Peru	Wed Sep 06 19:01:34 2023	per	hepb3	2008	93	93	1	99	99	99	494478	500672	626301	626301	92	interpolated		W: AP	Estimate of 93 percent assigned by working group.  Estimate is based on DTP3 coverage levels. Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: D-R-	
Peru	Wed Sep 06 19:01:34 2023	per	hepb3	2009	93	93	2	93	93	93	551504	596227	623635	623635	93	gov		R: AP	 Estimate is based on coverage reported by national government.   GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepb3	2010	93	93	3	93	93	93	548965	593470	617632	617632	93	gov		R:	Estimate informed by reported data.    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepb3	2011	91	91	3	91	91	91	537717	589273	613180	613180	91	gov		R:	Estimate informed by reported data.    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepb3	2012	95	95	3	95	95	95	554400	582056	602813	602813	95	gov	88	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 88 percent based on 1 survey(s).  Peru Continuous Demographic and Family Health Survey 2013 card or history results of 80 percent modifed for recall bias to 88 percent based on 1st dose card or history coverage of 93 percent, 1st dose card only coverage of 78 percent and 3rd dose card only coverage of 74 percent.   GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepb3	2013	88	88	3	88	88	88	506305	574322	592938	592938	88	gov		R:	Estimate informed by reported data. The 2014 ENDESA survey reporting coverage for children aged less than 12 months (87 percent of whom had documented evidence of vaccination history), born during 2013, suggests coverage (card+recall) of 70 percent modified for recall bias to 72 percent based on 1st dose card or history coverage of 89 percent, 1st dose card only coverage of 82 percent and 3d dose card only coverage of 66 percent.  GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepb3	2014	88	88	3	88	88	88	500868	567358	584699	584699	88	gov		R:	Estimate informed by reported data.  Increase in dropout due to multiple factors per EPI review 2014.  GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepb3	2015	90	90	2	90	90	90	507770	562442	577568	577568	90	gov		R:	Estimate informed by reported data.   GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepb3	2016	89	89	2	89	89	89	478326	539608	575208	575208	89	gov		R:	Estimate informed by reported data.   GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepb3	2017	89	83	1	79	79	79	451561	568870	576461	576461	89	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years. Estimate of 89 percent changed from previous revision value of 83 percent.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	hepb3	2018	88	84	2	97	97	97	517500	535761	579697	579697	88	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years. Estimate of 88 percent changed from previous revision value of 84 percent.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepb3	2019	88	88	1	88	88	88	445867	506008	591025	591025	88	gov		R:	Estimate informed by reported data.  Increase in reported coverage is partially due a six percent decrease in the reported target population from 2018 to 2019.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	hepb3	2020	72	72	1	72	72	72	365435	506008	593207	593207	72	gov		W:	 Estimate based on estimated DTP3 coverage level.  Decline in reported coverage is unexplained by country but aligns with COVID-19 pandemic service disruptions.  Estimate challenged by: D-R-	
Peru	Wed Sep 06 19:01:34 2023	per	hepb3	2021	82	82	1	82	82	82	412409	506008	593523	593523	82	gov		W:	 Estimate based on estimated DTP3 coverage level.   Estimate challenged by: D-R-	
Peru	Wed Sep 06 19:01:34 2023	per	hepb3	2022	82		1	82	82	82	406912	494595	592156	592156	82	gov		R:	Estimate informed by reported data.  WHO and UNICEF are aware of a 2021 Peru Encuesta Demográfica y de Salud Familiar-ENDES 2021 that reports DTP-HepB-Hib3 coverage of 81 percent for children under 36 months of age.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	hepbb	2003	60	60	2	60		60			615508	615508	60	admin		R:	Estimate informed by reported administrative data.    GoC=R+	
Peru	Wed Sep 06 19:01:34 2023	per	hepbb	2004	68	68	2	76	68	68	458766	605682	623674	623674	68	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepbb	2005	67	67	1	87		87	523021	602739	631197	631197	67	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded due to an increase from 68 percent to 87 percent with decrease 66 percent.   Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	hepbb	2006	66	66	2	66	66	66	363714	550011	634801	634801	66	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepbb	2007	73	73	1	36	36	36	181056	500748	632563	632563	73	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded due to decline in reported coverage from 66 percent to 36 percent with increase to 79 percent.   Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	hepbb	2008	79	79	1	79	79	79	397074	500672	626301	626301	79	gov		R:	Estimate informed by reported data.    Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	hepbb	2009	71	71	2	71	71	71	421797	596227	623635	623635	71	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepbb	2010	74	74	2	74	74	74	441682	593470	617632	617632	74	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepbb	2011	76	76	2	76	76	76	448011	589273	613180	613180	76	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepbb	2012	81	81	2	81	81	81	471715	582056	602813	602813	81	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepbb	2013	82	82	2	82	82	82	472499	574322	592938	592938	82	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepbb	2014	78	78	2	78	78	78	443123	567358	584699	584699	78	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepbb	2015	79	79	2	79	79	79	444345	562442	577568	577568	79	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepbb	2016	79	79	2	79	79	79	428108	539608	575208	575208	79	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepbb	2017	80	75	2	72	72	72	409824	568870	576461	576461	80	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years. Estimate of 80 percent changed from previous revision value of 75 percent.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepbb	2018	81	73	2	83	83	83	444129	535761	579697	579697	81	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years. Estimate of 81 percent changed from previous revision value of 73 percent.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hepbb	2019	82	82	1	82	82	82	413949	506008	591025	591025	82	gov		R:	Estimate informed by reported data.   Increase in reported coverage is partially due a six percent decrease in the reported target population from 2018 to 2019.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	hepbb	2020	75	75	1	75	75	75	378942	506008	593207	593207	75	gov		R:	Estimate informed by reported data.   Decline in reported coverage is unexplained by country but aligns with COVID-19 pandemic service disruptions.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	hepbb	2021	77	77	1	77	77	77	389837	506008	593523	593523	77	gov		R:	Estimate informed by reported data.    Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	hepbb	2022	79		1	79	79	79	391884	494595	592156	592156	79	gov		R:	Estimate informed by reported data.    Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	1998	12	12	1	7		7			640417	640417	7	admin		C:	Reported data calibrated to 2005 levels.   Hib vaccine partially introduced in 1999, nationally in 2005, and reporting started in 1998.  Estimate challenged by: R-	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	1999	28	28	1						636064	636064	23	interpolated		C:	Reported data calibrated to 2005 levels.    GoC=No accepted empirical data	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2000	43	43	1	38	38	38	224709	587552	633322	633322	38	gov		C:	Reported data calibrated to 2005 levels.    Estimate challenged by: R-	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2001	38	38	1	33	33	33		207980	620232	620232	33	gov		C:	Reported data calibrated to 2005 levels.    Estimate challenged by: R-	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2002	40	40	1	35	35	35			616261	616261	35	gov		C:	Reported data calibrated to 2005 levels.    Estimate challenged by: R-	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2003	41	41	1	36		36	209044	584275	615508	615508	36	admin		C:	Reported data calibrated to 2005 levels.    Estimate challenged by: R-	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2004	96	96	1	50	91	91	304699	605682	623674	623674	91	gov		C:	Reported data calibrated to 2005 levels.    Estimate challenged by: D-R-	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2005	94	94	1	89	89	89	445602	602739	631197	631197	89	gov		W: AP	Estimate of 94 percent assigned by working group.  Estimate is based on DTP3 coverage levels.   Estimate challenged by: D-R-	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2006	94	94	1	94	94	94	519429	550011	634801	634801	90	interpolated		W: AP	Estimate of 94 percent assigned by working group.  Estimate is based on DTP3 coverage levels. Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: D-R-	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2007	93	93	1	96	93	93	436988	500748	632563	632563	91	interpolated		W: AP	Estimate of 93 percent assigned by working group.  Estimate is based on DTP3 coverage levels. Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: D-R-	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2008	93	93	1	99	99	99	494478	500672	626301	626301	92	interpolated		W: AP	Estimate of 93 percent assigned by working group.  Estimate is based on DTP3 coverage levels. Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: D-R-	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2009	93	93	2	93	93	93	551504	596227	623635	623635	93	gov		R: AP	 Estimate is based on coverage reported by national government.   GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2010	93	93	3	93	93	93	548965	593470	617632	617632	93	gov		R:	Estimate informed by reported data.    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2011	91	91	3	91	91	91	537522	589273	613180	613180	91	gov		R:	Estimate informed by reported data.    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2012	95	95	3	95	95	95	554400	582056	602813	602813	95	gov	88	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 88 percent based on 1 survey(s).  Peru Continuous Demographic and Family Health Survey 2013 card or history results of 80 percent modifed for recall bias to 88 percent based on 1st dose card or history coverage of 93 percent, 1st dose card only coverage of 78 percent and 3rd dose card only coverage of 74 percent.   GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2013	88	88	3	88	88	88	506305	574322	592938	592938	88	gov		R:	Estimate informed by reported data.  The 2014 ENDESA survey reporting coverage for children aged less than 12 months (87 percent of whom had documented evidence of vaccination history), born during 2013, suggests coverage (card+recall) of 70 percent modified for recall bias to 72 percent based on 1st dose card or history coverage of 89 percent, 1st dose card only coverage of 82 percent and 3d dose card only coverage of 66 percent.  GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2014	88	88	3	88	88	88	500868	567358	584699	584699	88	gov		R:	Estimate informed by reported data.  Increase in dropout due to multiple factors per EPI review 2014.  GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2015	90	90	2	90	90	90	507770	562442	577568	577568	90	gov		R:	Estimate informed by reported data.   GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2016	89	89	2	89	89	89	478326	539608	575208	575208	89	gov		R:	Estimate informed by reported data.   GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2017	89	83	1	79	79	79	451561	568870	576461	576461	89	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years. Estimate of 89 percent changed from previous revision value of 83 percent.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2018	88	84	2	97	97	97	517500	535761	579697	579697	88	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years. Estimate of 88 percent changed from previous revision value of 84 percent.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2019	88	88	1	88	88	88	445867	506008	591025	591025	88	gov		R:	Estimate informed by reported data.  Increase in reported coverage is partially due a six percent decrease in the reported target population from 2018 to 2019.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2020	72	72	1	72	72	72	365435	506008	593207	593207	72	gov		W:	 Estimate based on DTP3.  Decline in reported coverage is unexplained by country but aligns with COVID-19 pandemic service disruptions.  Estimate challenged by: D-R-	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2021	82	82	1	82	82	82	412409	506008	593523	593523	82	gov		W:	 Estimate based on estimated DTP3 coverage level.   Estimate challenged by: D-R-	
Peru	Wed Sep 06 19:01:34 2023	per	hib3	2022	82		1	82	82	82	406912	494595	592156	592156	82	gov		R:	Estimate informed by reported data.  WHO and UNICEF are aware of a 2021 Peru Encuesta Demográfica y de Salud Familiar-ENDES 2021 that reports DTP-HepB-Hib3 coverage of 81 percent for children under 36 months of age.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	ipv1	2015	98	98	2	98	98	98	552623	562442	577568	577568	98	gov		R:	Estimate informed by reported data.   Inactivated polio vaccine was introduced in 2014. Sequential schedule is used with IPV recommended at 2 and 4 month.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	ipv1	2016	94	94	2	94	94	94	504884	539608	575208	575208	94	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	ipv1	2017	95	90	1	86	86	86	487129	568870	576461	576461	95	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years. Estimate of 95 percent changed from previous revision value of 90 percent.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	ipv1	2018	95	89	2	104	104	104	558801	535761	579697	579697	95	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years.Reported data excluded because 104 percent greater than 100 percent.  Estimate of 95 percent changed from previous revision value of 89 percent.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	ipv1	2019	96	91	2	96	96	96			591025	591025	96	gov		R:	Estimate informed by reported data.   Estimate of 96 percent changed from previous revision value of 91 percent.  GoC=R+	
Peru	Wed Sep 06 19:01:34 2023	per	ipv1	2020	92	92	1	92	92	92	467884	506008	593207	593207	92	gov		R:	Estimate informed by reported data.   Decline in reported coverage is unexplained by country but aligns with COVID-19 pandemic service disruptions.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	ipv1	2021	89	89	1	89	89	89	451367	506008	593523	593523	89	gov		R:	Estimate informed by reported data.    Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	ipv1	2022	93		1	93	93	93	457886	494595	592156	592156	93	gov		R:	Estimate informed by reported data.   WHO and UNICEF are aware of a 2021 Peru Encuesta Demográfica y de Salud Familiar-ENDES 2021 that reports IPV1 coverage of 94 percent for children under 36 months of age.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	1997	91	91	2		91	91			646054	646054	91	gov		R: AP	Legacy estimate.   GoC=R+ S+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	1998	93	93	2		93	93			640417	640417	93	gov		R:	Estimate informed by reported data.    GoC=R+ S+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	1999	93	93	2	93	93	93			636064	636064	93	gov	84	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 84 percent based on 1 survey(s).    GoC=R+ S+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2000	97	97	1	97	97	97			633322	633322	97	gov		R:	Estimate informed by reported data.    Estimate challenged by: S-	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2001	97	97	1	97	97	97	571	578531	620232	620232	97	gov		R:	Estimate informed by reported data.    Estimate challenged by: D-S-	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2002	95	95	2	95	95	95			616261	616261	95	gov		R:	Estimate informed by reported data.    GoC=R+ S+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2003	95	95	1	95	95	95	546192	576725	615508	615508	95	gov	89	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 89 percent based on 2 survey(s).    Estimate challenged by: S-	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2004	85	85	1	89	89	89	536543	605682	623674	623674	94	interpolated		C:	Reported data calibrated to 2003 and 2005 levels.  Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: R-	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2005	77	77	1	80	80	80	598244	1948595	631197	631197	94	interpolated	77	S: AP	Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 77 percent based on 1 survey(s).   Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: D-R-S-	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2006	93	93	1	102	100	100	557468	548806	634801	634801	93	interpolated	83	R: AP	Estimate informed by interpolation between reported data supported by survey. Survey evidence of 83 percent based on 1 survey(s).  Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: S-	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2007	92	92	1	95	95	95	496190	520997	632563	632563	92	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: D-S-	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2008	92	92	1	90	90	90	469779	520829	626301	626301	92	interpolated		R:	Estimate informed by interpolation between reported data.  Peru Continuous Demographic and Health Survey 2009 results ignored by working group.  Survey results ignored. Adjustment factor for recall bias inconsistent with other surveys of similar quality and methodology.Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2009	91	91	3	91	91	91	539887	592773	623635	623635	91	gov	83	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 83 percent based on 1 survey(s).    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2010	94	94	1	94	94	94	554536	590556	617632	617632	94	gov	88	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 88 percent based on 1 survey(s).    Estimate challenged by: S-	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2011	96	96	1	95	96	96	562396	588925	613180	613180	96	gov	90	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 90 percent based on 1 survey(s).    Estimate challenged by: S-	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2012	94	94	3	94	94	94	547594	583743	602813	602813	94	gov	85	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 85 percent based on 1 survey(s).    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2013	85	85	3	85	85	85	489589	578077	592938	592938	85	gov		R:	Estimate informed by reported data.   GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2014	89	89	3	89	89	89	507221	572711	584699	584699	89	gov		R:	Estimate informed by reported data.   GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2015	92	92	2	92	92	92	525199	568417	577568	577568	92	gov		R:	Estimate informed by reported data.   GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2016	88	88	2	88	88	88	487027	553536	575208	575208	88	gov		R:	Estimate informed by reported data.   GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2017	87	83	2	82	82	82	461672	566250	576461	576461	87	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years. Estimate of 87 percent changed from previous revision value of 83 percent.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2018	86	85	2	99	99	99	510238	553277	579697	579697	86	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years.Reported data excluded due to an increase from 82 percent to 99 percent with decrease 85 percent.  Estimate of 86 percent changed from previous revision value of 85 percent.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2019	85	85	2	85	85	85	469481	553993	591025	591025	85	gov		R:	Estimate informed by reported data.   GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2020	77	77	2	77	77	77	427078	553993	593207	593207	77	gov		R:	Estimate informed by reported data.  Decline in reported coverage is unexplained by country but aligns with COVID-19 pandemic service disruptions.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2021	78	78	2	78	78	78	434356	553993	593523	593523	78	gov		R:	Estimate informed by reported data.   GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv1	2022	74		2	74	74	74	397567	537207	592156	592156	74	gov		R:	Estimate informed by reported data.  WHO and UNICEF are aware of a 2021 Peru Encuesta Demográfica y de Salud Familiar-ENDES 2021 that reports MCV1 coverage of 83 percent for children under 36 months of age.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv2	2007	9	9	2	9	9	9	49272	556370	632563	632563	9	gov		R:	Estimate informed by reported data.   Measles 2nd dose was introduced in 2007 and recommended at 4 years of age.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv2	2008	17	17	2	17	17	17	94687	550860	626301	626301	17	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv2	2009	42	42	2	42	42	42	249600	591426	623635	623635	42	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv2	2010	56	56	2	56	56	56	333910	591426	617632	617632	56	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv2	2011	70	70	1	70	70	70	362093	516658	613180	613180	70	gov		R:	Estimate informed by reported data.    Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	mcv2	2012	63	63	2	63	63	63	368024	586752	602813	602813	63	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv2	2013	54	54	2	54	54	54	314183	585140	592938	592938	54	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv2	2014	44	44	2	44	44	44	253942	572711	584699	584699	44	gov		R:	Estimate informed by reported data.   Second dose of measles containing vaccine (MCV2) recommended at age 18 months from 2014.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv2	2015	63	63	2	63	63	63	358342	568417	577568	577568	63	gov		R:	Estimate informed by reported data.   Increase from previous year can be attributed to full year with the new schedule.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv2	2016	66	66	2	66	66	66	366704	553536	575208	575208	66	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv2	2017	66	66	2	65	65	65	368219	566250	576461	576461	66	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv2	2018	66	66	2	75	75	75	416246	553277	579697	579697	66	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv2	2019	66	66	2	66	66	66	364916	553993	591025	591025	66	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv2	2020	52	52	2	52	52	52	289439	553993	593207	593207	52	gov		R:	Estimate informed by reported data.   Decline in reported coverage is unexplained by country but aligns with COVID-19 pandemic service disruptions..  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv2	2021	60	60	2	60	60	60	331074	553993	593523	593523	60	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	mcv2	2022	54		2	54	54	54	289139	537207	592156	592156	54	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pcv3	2009	9	9	2	9	9	9	52080	592773	623635	623635	9	gov		R:	Estimate informed by reported data.   Pneumococcal conjugate vaccine partially introduced in 2007 nationally in 2009 reporting started in 2009.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pcv3	2010	83	83	2	83	83	83	491455	590556	617632	617632	83	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pcv3	2011	82	82	2	82	82	82			613180	613180	82	gov		R:	Estimate informed by reported data.    GoC=R+	
Peru	Wed Sep 06 19:01:34 2023	per	pcv3	2012	89	89	2	89	89	89	521111	583743	602813	602813	89	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pcv3	2013	85	85	2	85	85	85	491935	578077	592938	592938	85	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pcv3	2014	86	86	2	86	86	86	491482	572711	584699	584699	86	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pcv3	2015	90	90	2	90	90	90	509015	568417	577568	577568	90	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pcv3	2016	86	86	2	86	86	86	474405	553536	575208	575208	86	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pcv3	2017	84	80	2	79	79	79	445033	566250	576461	576461	84	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years. Estimate of 84 percent changed from previous revision value of 80 percent.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pcv3	2018	82	82	2	94	94	94	518265	553277	579697	579697	82	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years.Reported data excluded due to an increase from 79 percent to 94 percent with decrease 80 percent.   GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pcv3	2019	80	80	2	80	80	80	444787	553993	591025	591025	80	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pcv3	2020	74	74	2	74	74	74	408536	553993	593207	593207	74	gov		R:	Estimate informed by reported data.   Decline in reported coverage is unexplained by country but aligns with COVID-19 pandemic service disruptions.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pcv3	2021	75	75	2	75	75	75	416178	553993	593523	593523	75	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pcv3	2022	71		2	71	71	71	379581	537207	592156	592156	71	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	1997	91	91	1		97	97			646054	646054	97	gov		W: AP	Estimate of 91 percent assigned by working group. Legacy estimate.   Estimate challenged by: R-	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	1998	93	93	1		96	96			640417	640417	96	gov		C:	Reported data calibrated to 1997 and 1999 levels.    Estimate challenged by: R-	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	1999	96	96	2	96	96	96			636064	636064	96	gov	89	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 89 percent based on 1 survey(s).  NA card or history results of 76 percent modifed for recall bias to 89 percent based on 1st dose card or history coverage of 96 percent, 1st dose card only coverage of 58 percent and 3rd dose card only coverage of 54 percent.   GoC=R+ S+	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2000	93	93	2	93	93	93			633322	633322	93	gov		R:	Estimate informed by reported data.    GoC=R+ S+	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2001	90	90	3	90	90	90	538478	586577	620232	620232	90	gov		R:	Estimate informed by reported data.    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2002	95	95	2	95	95	95			616261	616261	95	gov		R:	Estimate informed by reported data.    GoC=R+ S+	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2003	95	95	1	95	95	95	552863	584275	615508	615508	95	gov	95	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 95 percent based on 2 survey(s).  Peru Demographic and Health Survey 2004 card or history results of 81 percent modifed for recall bias to 96 percent based on 1st dose card or history coverage of 97 percent, 1st dose card only coverage of 66 percent and 3rd dose card only coverage of 65 percent. Peru Demographic and Health Survey, 2004-2008 - Final Report Continuous (2004-2005) card or history results of 79 percent modifed for recall bias to 94 percent based on 1st dose card or history coverage of 97 percent, 1st dose card only coverage of 68 percent and 3rd dose card only coverage of 66 percent.   Estimate challenged by: S-	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2004	81	81	1	91	91	91	549419	605682	623674	623674	95	interpolated		C:	Reported data calibrated to 2003 and 2005 levels.  Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: R-S-	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2005	66	66	1	85	85	85	512955	602739	631197	631197	94	interpolated	66	S: AP	Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 66 percent based on 1 survey(s).   Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: D-R-S-	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2006	94	94	1	95	95	95	520886		634801	634801	94	interpolated	86	R: AP	Estimate informed by interpolation between reported data supported by survey. Survey evidence of 86 percent based on 1 survey(s).  Peru Continuous Demographic and Family Health Survey 2007-2008 card or history results of 69 percent modifed for recall bias to 86 percent based on 1st dose card or history coverage of 94 percent, 1st dose card only coverage of 62 percent and 3rd dose card only coverage of 57 percent. Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: D-S-	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2007	93	93	1	96	96	96	437479		632563	632563	93	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: D-S-	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2008	93	93	1	98	98	98	488926	500672	626301	626301	93	interpolated		R:	Estimate informed by interpolation between reported data.  Peru Continuous Demographic and Health Survey 2009 results ignored by working group.  Survey results ignored. Adjustment factor for recall bias inconsistent with other surveys of similar quality and methodology.Peru Continuous Demographic and Health Survey 2009 card or history results of 68 percent modifed for recall bias to 85 percent based on 1st dose card or history coverage of 92 percent, 1st dose card only coverage of 63 percent and 3rd dose card only coverage of 58 percent. Reported data excluded.  National reported data in 2006-2008 exceed 100 percent for some antigens and are not consistent with coverage recalculated using UNPD denominators.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2009	92	92	3	92	92	92	549700	596227	623635	623635	92	gov	84	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 84 percent based on 1 survey(s).  Peru Continuous Demographic and Family Health Survey 2010 card or history results of 76 percent modifed for recall bias to 84 percent based on 1st dose card or history coverage of 92 percent, 1st dose card only coverage of 73 percent and 3rd dose card only coverage of 67 percent.   GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2010	92	92	3	92	92	92	546574	593470	617632	617632	92	gov	92	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 92 percent based on 1 survey(s).  Peru Continuous Demographic and Family Health Survey 2011 card or history results of 85 percent modifed for recall bias to 92 percent based on 1st dose card or history coverage of 97 percent, 1st dose card only coverage of 79 percent and 3rd dose card only coverage of 75 percent.   GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2011	91	91	3	91	91	91	538022	589273	613180	613180	91	gov	94	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 94 percent based on 1 survey(s).  Peru Continuous Demographic and Family Health Survey 2012 card or history results of 86 percent modifed for recall bias to 94 percent based on 1st dose card or history coverage of 98 percent, 1st dose card only coverage of 80 percent and 3rd dose card only coverage of 77 percent.   GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2012	94	94	3	94	94	94	547030	582056	602813	602813	94	gov	92	R: AP	Estimate informed by reported data supported by survey. Survey evidence of 92 percent based on 1 survey(s).  Peru Continuous Demographic and Family Health Survey 2013 card or history results of 84 percent modifed for recall bias to 92 percent based on 1st dose card or history coverage of 97 percent, 1st dose card only coverage of 78 percent and 3rd dose card only coverage of 74 percent.   GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2013	71	71	1	71	71	71	406714	574322	592938	592938	71	gov		R:	Estimate informed by reported data. The 2014 ENDESA survey reporting coverage for children aged less than 12 months (87 percent of whom had documented evidence of vaccination history), born during 2013, suggests coverage (card+recall) of 51 percent modified for recall bias to 55 percent based on 1st dose card or history coverage of 81 percent, 1st dose card only coverage of 72 percent and 3d dose card only coverage of 49 percent. In 2013, Peru introduced a sequential schedule with IPV1, IPV2, OPV3, OPV4 and a fifth dose of OPV at 4 years. Decline in reported coverage may also be partly explained by a stockout of polio vaccine.  Estimate challenged by: S-	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2014	78	78	1	78	78	78	375126	567358	584699	584699	78	gov		R:	Estimate informed by reported data.   Estimate challenged by: D-S-	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2015	88	88	2	88	88	88	492197	562442	577568	577568	88	gov		R:	Estimate informed by reported data.   GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2016	88	88	2	88	88	88	473584	539608	575208	575208	88	gov		R:	Estimate informed by reported data.   GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2017	88	83	2	79	79	79	450062	568870	576461	576461	88	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years. Estimate of 88 percent changed from previous revision value of 83 percent.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2018	87	83	2	96	96	96	512285	535761	579697	579697	87	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years. Estimate of 87 percent changed from previous revision value of 83 percent.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2019	87	87	1	87	87	87	441631	506008	591025	591025	87	gov		R:	Estimate informed by reported data.  Increase in reported coverage is partially due a six percent decrease in the reported target population from 2018 to 2019.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2020	72	72	1	72	72	72	362189	506008	593207	593207	72	gov		W:	 Estimate is informed by a recalculation of reported numerator for the first dose of oral polio vaccine, which is the third dose of polio vaccine in the schedule, and surviving infants.  Decline in reported coverage is unexplained by country but aligns with COVID-19 pandemic service disruptions..  Estimate challenged by: D-R-	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2021	79	79	1	79	79	79	398605	506008	593523	593523	79	gov		W:	 Estimate is informed by a recalculation of reported numerator for the first dose of oral polio vaccine, which is the third dose of polio vaccine in the schedule, and surviving infants.   Estimate challenged by: D-R-	
Peru	Wed Sep 06 19:01:34 2023	per	pol3	2022	82		1	82	82	82	404416	494595	592156	592156	82	gov		R:	Estimate informed by reported data.  WHO and UNICEF are aware of a 2021 Peru Encuesta Demográfica y de Salud Familiar-ENDES 2021 that reports Polio3 coverage of 83 percent for children under 36 months of age.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	rcv1	2003	95	95	1						615508	615508				R: AP	Estimate based on estimated MCV1.    Estimate challenged by: S-	
Peru	Wed Sep 06 19:01:34 2023	per	rcv1	2004	85	85	1						623674	623674				C:	Estimate based on estimated MCV1.    Estimate challenged by: R-	
Peru	Wed Sep 06 19:01:34 2023	per	rcv1	2005	77	77	1						631197	631197				S: AP	Estimate based on estimated MCV1.    Estimate challenged by: D-R-S-	
Peru	Wed Sep 06 19:01:34 2023	per	rcv1	2006	93	93	1						634801	634801				R: AP	Estimate based on estimated MCV1.    Estimate challenged by: S-	
Peru	Wed Sep 06 19:01:34 2023	per	rcv1	2007	92	92	1						632563	632563				R:	Estimate based on estimated MCV1.    Estimate challenged by: D-S-	
Peru	Wed Sep 06 19:01:34 2023	per	rcv1	2008	92	92	1						626301	626301				R:	Estimate based on estimated MCV1.    Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	rcv1	2009	91	91	3						623635	623635				R: AP	Estimate based on estimated MCV1.    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rcv1	2010	94	94	1						617632	617632				R: AP	Estimate based on estimated MCV1.    Estimate challenged by: S-	
Peru	Wed Sep 06 19:01:34 2023	per	rcv1	2011	96	96	1						613180	613180				R: AP	Estimate based on estimated MCV1.    Estimate challenged by: S-	
Peru	Wed Sep 06 19:01:34 2023	per	rcv1	2012	94	94	3						602813	602813				R: AP	Estimate based on estimated MCV1.    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rcv1	2013	85	85	3						592938	592938				R:	Estimate based on estimated MCV1.    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rcv1	2014	89	89	3						584699	584699				R:	Estimate based on estimated MCV1.    GoC=R+ S+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rcv1	2015	92	92	2						577568	577568				R:	Estimate based on estimated MCV1.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rcv1	2016	88	88	2						575208	575208				R:	Estimate based on estimated MCV1.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rcv1	2017	87	83	2						576461	576461				R:	Estimate based on estimated MCV1.   Estimate of 87 percent changed from previous revision value of 83 percent.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rcv1	2018	86	85	2						579697	579697				R:	Estimate based on estimated MCV1.   Estimate of 86 percent changed from previous revision value of 85 percent.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rcv1	2019	85	85	2						591025	591025				R:	Estimate based on estimated MCV1.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rcv1	2020	77	77	2						593207	593207				R:	Estimate based on estimated MCV1.   Decline in reported coverage is unexplained by country but aligns with COVID-19 pandemic service disruptions.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rcv1	2021	78	78	2						593523	593523				R:	Estimate based on estimated MCV1.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rcv1	2022	74		2						592156	592156				R:	Estimate based on estimated MCV1.   WHO and UNICEF are aware of a 2021 Peru Encuesta Demográfica y de Salud Familiar-ENDES 2021 that reports MCV1 coverage of 83 percent for children under 36 months of age.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rotac	2008	3	3	2	3		3	13965	500672	626301	626301	3	admin		R:	Estimate informed by reported administrative data.   Rotavirus vaccine partially introduced in 2007, nationally in 2009, reporting started in 2008.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rotac	2009	41	41	2	41	41	41	244737	596227	623635	623635	41	gov		R:	Estimate informed by reported data.  .  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rotac	2010	75	75	2	75	75	75	444008	593470	617632	617632	75	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rotac	2011	84	84	2	84	84	84	492135	589273	613180	613180	84	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rotac	2012	91	91	2	91	91	91	528642	582056	602813	602813	91	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rotac	2013	86	86	2	86	86	86	495645	574322	592938	592938	86	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rotac	2014	86	86	2	86	86	86	489582	567358	584699	584699	86	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rotac	2015	87	87	2	87	87	87	491601	562442	577568	577568	87	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rotac	2016	87	87	2	87	87	87	468823	539608	575208	575208	87	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rotac	2017	88	85	2	81	81	81	458983	568870	576461	576461	88	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years. Estimate of 88 percent changed from previous revision value of 85 percent.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	rotac	2018	89	85	1	99	99	99	829811	535761	579697	579697	89	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years. Estimate of 89 percent changed from previous revision value of 85 percent.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	rotac	2019	90	90	1	90	90	90	456938	506008	591025	591025	90	gov		R:	Estimate informed by reported data.   Increase in reported coverage is partially due a six percent decrease in the reported target population from 2018 to 2019.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	rotac	2020	76	76	1	76	76	76	383338	506008	593207	593207	76	gov		R:	Estimate informed by reported data.   Decline in reported coverage is unexplained by country but aligns with COVID-19 pandemic service disruptions..  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	rotac	2021	82	82	1	82	82	82	415876	506008	593523	593523	82	gov		R:	Estimate informed by reported data.    Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	rotac	2022	84		1	84	84	84	413756	494595	592156	592156	84	gov		R:	Estimate informed by reported data.    Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2000	8	8	2	8	8	8	45737	587552	633322	633322	8	gov		R:	Estimate informed by reported data.   YFV introduced nationally in 2002, reporting started in 2000.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2001	26	26	2	26	26	26	153258	586577	620232	620232	26	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2002	36	36	1						616261	616261	36	interpolated		R:	Estimate informed by interpolation between reported data.    GoC=No accepted empirical data	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2003	47	47	1						615508	615508	47	interpolated		R:	Estimate informed by interpolation between reported data.    GoC=No accepted empirical data	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2004	57	57	2	57	57	57	344239	599572	623674	623674	57	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2005	78	78	2	78	78	78	463383	596622	631197	631197	78	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2006	91	91	1	91	91	91	499808	548806	634801	634801	91	gov		R:	Estimate informed by reported data.    Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2007	87	87	1	87	87	87	454807	520997	632563	632563	87	gov		R:	Estimate informed by reported data.    Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2008	82	82	1	82	82	82	428099	520829	626301	626301	82	gov		R:	Estimate informed by reported data.    Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2009	66	66	2	66	66	66	389741	592773	623635	623635	66	gov		R:	Estimate informed by reported data.   Due to vaccine shortages YFV administered in districts at risk only.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2010	61	61	2	61	61	61	359400	590556	617632	617632	61	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2011	51	51	2	59	51	51	347485	588925	613180	613180	51	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2012	58	58	2	58		58	339489	583743	602813	602813	58	admin		R:	Estimate informed by reported administrative data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2013	64	64	2	64	64	64	369172	578077	592938	592938	64	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2014	65	65	2	65	65	65	374209	572711	584699	584699	65	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2015	67	67	2	67	67	67	380898	568417	577568	577568	67	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2016	64	64	2	64	64	64	352215	553536	575208	575208	64	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2017	62	63	2	62	62	62	348847	566250	576461	576461	62	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years. Estimate of 62 percent changed from previous revision value of 63 percent.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2018	59	65	1	75	75	75	414658	553277	579697	579697	59	interpolated		R:	Estimate informed by interpolation between reported data.  Reported data excluded.  Reported target population increased 5.4 percent between 2016 and 2017 followed by a decrease of 5.8 percent between 2017 and 2018. In addition, the number of doses administered during 2018 was exceptionally higher than prior years.Reported data excluded due to an increase from 62 percent to 75 percent with decrease 57 percent.  Estimate of 59 percent changed from previous revision value of 65 percent.  Estimate challenged by: D-	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2019	57	57	2	57	57	57	317629	553993	591025	591025	57	gov		R:	Estimate informed by reported data.   Programme reports national and subnational vaccine stockout of unknown duration.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2020	50	50	2	50	50	50	278104	553993	593207	593207	50	gov		R:	Estimate informed by reported data.   Decline in reported coverage is unexplained by country but aligns with COVID-19 pandemic service disruptions.  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2021	61	61	2	61	61	61	336284	553993	593523	593523	61	gov		R:	Estimate informed by reported data.  .  GoC=R+ D+	
Peru	Wed Sep 06 19:01:34 2023	per	yfv	2022	52		2	52	52	52	276939	537207	592156	592156	52	gov		R:	Estimate informed by reported data.    GoC=R+ D+	
